Literature DB >> 7944626

Microheterogeneity of alpha 1-acid glycoprotein in patients with rheumatoid arthritis.

J K Lacki, M Sobieska, P Leszczynski, K Wiktorowicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7944626      PMCID： PMC1005378          DOI： 10.1136/ard.53.7.480-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  Methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; J M Kremer
Journal:  J Am Acad Dermatol       Date:  1988-07       Impact factor: 11.527

2.  Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography.

Authors:  T C Bog-Hansen
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

3.  Methotrexate in rheumatoid arthritis.

Authors:  J H Klippel; J L Decker
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

4.  The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

Authors:  J M Kremer; J K Lee
Journal:  Arthritis Rheum       Date:  1986-07

5.  Methotrexate in refractory rheumatoid arthritis.

Authors:  A M Boerbooms; M E Jeurissen; A A Westgeest; H Theunisse; L B Van de Putte
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

6.  Microheterogeneity of alpha 1-acid glycoprotein in the detection of intercurrent infection in patients with rheumatoid arthritis.

Authors:  T Pawlowski; S H Mackiewicz; A Mackiewicz
Journal:  Arthritis Rheum       Date:  1989-03

7.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01
  7 in total
  1 in total

1.  Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?

Authors:  Izabela Korczowska; Anna Olewicz-Gawlik; Jakub Trefler; Paweł Hrycaj; Jan Krzysztof Łacki
Journal:  Clin Rheumatol       Date:  2007-10-02       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.